2.26
2.26 (0%)
As of Feb 14, 2025
Stereotaxis, Inc. [STXS]
Source:
Company Overview
Stereotaxis designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. Our proprietaryrobotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlledmagnetic fields to directly control the tip of flexible interventional catheters or devices.
Country | United States |
Headquarters | st.louis, missouri |
Phone Number | 314-678-6100 |
Industry | manufacturing |
CEO | David L. Fischel |
Website | http://www.stereotaxis.com |
Financial Year:
Financial Overview (Dollars in Millions)
Revenue | $26.9 |
Operating Profit | $-24.7 |
Net Income | $-24 |
Net Cash | $-8.1 |
Profit Ratios
Gross Margin | $14.6 |
Operating Margin | -91.9 |
Profit as % of Revenues | -60.7% |
Profit as % of Assets | -54.3% |
Profit as % of Stockholder Equity | -395.5% |
Management Effectiveness
Return on Equity | -395.5% |
Return on Assets | -51.5% |
Turnover Ratio | 60.7% |
EBITA | $-24.7 |
Balance Sheet and Cash Flow Measures
Total Assets | $46.7 |
Total Liabilities | $35.3 |
Operating Cash Flow | $-8.5 |
Investing Cash Flow | $0.1 |
Financing Cash Flow | $0.3 |